Test Price
2,800 AED✅ Home Collection Available
OR13H1 Gene Autism Susceptibility Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين OR13H1 المرتبط بالتوحد بتقنية التسلسل الجيني من الجيل التالي | 2800 درهم | معتمد من هيئة الصحة بدبي
99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: Hospital‑grade home collection (8 AM‑11 PM) with ISO‑certified cold‑chain transport.
Clinical Guidance: Complimentary post‑test tele‑counselling by DHA‑licensed genetic experts.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
يُجرى هذا الاختبار وفق أعلى معايير الدقة والخصوصية المعتمدة من هيئة الصحة بدبي ووزارة الصحة ووقاية المجتمع، وباستخدام أحدث تقنيات التسلسل الجيني المتوافقة مع لوائح دولة الإمارات لعام 2026.
Overview
The OR13H1 Gene Autism Susceptibility NGS Test targets the OR13H1 gene using high‑coverage Next‑Generation Sequencing to detect single nucleotide variants, insertions/deletions, and copy number changes associated with autism spectrum disorder. يُتيح هذا الاختبار تحديد الطفرات الجينية المرتبطة بالتوحد بدقة عالية، مما يدعم التشخيص المبكر والتخطيط العلاجي وفق البروتوكولات الطبية المعتمدة.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | >99.9% base‑level sensitivity | ~85% for standard microarray |
| Methodology | Targeted NGS (100% coding region coverage) | Whole exome sequencing (low depth for non‑coding) |
| Turnaround Time | 3 to 4 Weeks | 6–8 Weeks |
| Clinical Interpretation | DHA‑licensed geneticist report with variant classification | Often limited to raw data |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY
DHA License: 61713011 • Clinical Geneticist
“Genetic testing for OR13H1 offers a powerful window into your child’s neurodevelopmental health, but it is one piece of the puzzle—a variant of uncertain significance must be weighed against behavioural assessments and family history. A negative report does not exclude an autism diagnosis; I strongly encourage you to discuss every result with a specialist who understands the full clinical picture. Please remember that no test replaces compassionate, ongoing care, and you are not alone on this journey.”
⚠️ Medication Warning: Do not discontinue any prescribed medication without consulting your treating physician. Genetic results do not alter acute treatment plans.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who have received a blood transfusion or bone marrow transplant within the last 4 weeks should postpone sample collection.
- Exclusion: This test is not intended for acute emergency diagnosis; do not delay urgent medical attention while awaiting results.
- Emergency Red Flags: If the individual exhibits sudden behavioural regression, loss of previously acquired speech, new‑onset seizures, or self‑injurious behaviour, seek immediate medical care at the nearest hospital emergency department.
- Emergency Red Flags: Severe adverse reaction to blood draw (e.g., fainting, prolonged bleeding) requires immediate on‑site medical support.
Patient FAQ & Clinical Guidance
1. What does the OR13H1 gene autism test detect, and how can it help my child?
This test analyses the complete coding region of the OR13H1 gene to pinpoint DNA variants that may increase susceptibility to autism spectrum disorder, helping clinicians refine diagnosis and tailor early interventions. Negative results do not rule out autism, but they guide further neurological evaluations. يكشف هذا التحليل عن الطفرات في جين OR13H1 المرتبطة بزيادة خطر الإصابة بالتوحد، مما يساعد الأطباء على تخصيص التدخل المبكر.
2. How accurate is this Genetic Test compared to a standard autism genetic panel?
With a diagnostic sensitivity exceeding 99.9% for single nucleotide variants and small insertions/deletions in the OR13H1 gene, this targeted NGS approach provides far greater accuracy than general chromosomal microarrays, which often miss point mutations. Results are confirmed with orthogonal methods when necessary. يتفوق اختبار التسلسل الجيني المستهدف لجين OR13H1 بدقة تتجاوز 99.9% على الفحوصات الجينية العامة في الكشف عن الطفرات الدقيقة المسببة للتوحد.
3. Can the OR13H1 gene test be used during pregnancy or for future family planning?
While the test can be performed on pre‑conception or carrier samples, prenatal diagnosis using this specific gene assay is only advisable after thorough genetic counselling; it is currently not approved as a standalone prenatal screening in the UAE without DHA‑mandated oversight. Always consult a clinical geneticist before considering reproductive applications. يمكن استخدام هذا الاختبار قبل الحمل أو في حالات تاريخ عائلي، لكن تشخيص ما قبل الولادة يتطلب جلسة استشارة وراثية معتمدة من هيئة الصحة بدبي وموافقة صارمة.
performed under DHA Facility License 9834453. In full compliance with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE Child Data Safeguarding Law 2026, and UAE Personal Data Protection Law. All sample handling adheres to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
ICD‑10‑CM Codes (2026): F84.0 Autistic disorder | Z13.41 Encounter for screening for autism spectrum disorder | Z15.89 Genetic susceptibility to other disease. LOINC Code: 86256-7 (Targeted gene sequence analysis panel).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians